Table 2 Demographics and personal cancer history across groups
From: Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes
| Â | High Risk Group | Low Risk Group |
|---|---|---|
Number of probands | 197 | 123 |
Average age of probands | 42.80 years (range 19–75) | 44.85 years (range 29–68) |
Sex of probands (N, % of group) | ||
 Female | 197 (100) | 123 (100) |
 Male | 0 (0) | 0 (0) |
Ethnicity (N, % of group) | ||
 African American | 11 (5.58) | 6 (4.88) |
 Ashkenazi Jewish | 17 (8.63) | 7 (5.69) |
 Asian | 7 (3.55) | 6 (4.88) |
 Caucasian | 145 (73.60) | 95 (77.24) |
 Hispanic | 9 (4.57) | 6 (4.88) |
 Native American | 5 (2.54) | 2 (1.63) |
 Unknown or Not Reported | 3 (1.52) | 1 (0.81) |
Personal cancer history (N, % of group) | ||
 Number of Probands with Personal History | 55 (27.92) | 18 (14.63%) |
 Number of Tumors | 58 (N/A) | 18 (N/A) |
Personal history: cancer type (N, % of tumors) | ||
 Breast (Total) | 42 (72.41) | 3 (16.67) |
  Breast (Unspecified) | 37 (63.79) | 3 (16.67) |
  Breast – DCIS | 2 (3.45) | 0 (0) |
  Breast – Triple Negative | 3 (5.17) | 0 (0) |
 Cervical | 2 (3.45) | 3 (16.67) |
 Fallopian Tube Cancer | 1 (1.72) | 0 |
 Melanoma | 3 (5.17) | 4 (22.22) |
 Non-Hodgkin’s Lymphoma | 2 (3.45) | 1 (5.56) |
 Ovarian | 4 (6.90) | 0 (0) |
 Skin (unspecified) | 2 (3.45) | 3 (16.67) |
 Thyroid | 1 (1.72) | 3 (16.67 |
 Uterine | 0 (0) | 1 (5.56) |
 Wilms’ Tumor | 1 (1.72) | 0 (0) |